🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Miloš D. Miljković

VLP Therapeutics (United States)

ORCID: 0000-0001-5848-6320

Also affiliated with National Cancer Institute, Cara Therapeutics (United States), Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study”.

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

The Lancet Neurology(2023)10.1016/s1474-4422(23)00194-1

N/A

5.4DataRank · unranked

260 citations

Michael Benatar, Metin Kurtoğlu, Miloš D. Miljković, Nizar Chahin, Gregory Sahagian +37 more

IL-15 in the Combination Immunotherapy of Cancer

Frontiers in Immunology(2020)10.3389/fimmu.2020.00868

N/A

4.1DataRank · unranked

253 citations

Sigrid Dubois, Miloš D. Miljković, Kevin C. Conlon, Thomas A. Waldmann

Next-Generation Sequencing-Based Monitoring of Circulating Tumor DNA Reveals Clonotypic Heterogeneity in Untreated PTCL

Blood Advances(2021)10.1182/bloodadvances.2020003679

N/A

0.828DataRank · unranked

22 citations

Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Andrea N. Lucas, Allison P. Jacob +5 more

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies

Blood Advances(2022)10.1182/bloodadvances.2021006440

N/A

0.756DataRank · unranked

21 citations

Sigrid Dubois, Jürgen R. Müller, Bonita R. Bryant, J. Elaine, Kevin C. Conlon +2 more

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology(2025)10.1002/acn3.70167

N/A

0.453DataRank · unranked

14 citations

Gregory Sahagian, Marc H. Feinberg, Charles A. Stewart, Christopher M. Jewell, Metin Kurtoğlu +6 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Blood Neoplasia(2024)10.1016/j.bneo.2024.100054

N/A

0.165DataRank · unranked

2 citations

Sigrid Dubois, Miloš D. Miljković, Samuel Y. Ng, Bonita R. Bryant, Rahul Lakhotia +8 more

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

Translational Oncology(2020)10.1016/j.tranon.2020.100913

N/A

0DataRank · unranked

13 citations

Yuquan Lin, Meili Zhang, Bonita R. Bryant, Michael Petrus, Richard N. Bamford +5 more

Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018

JAMA Internal Medicine(2020)10.1001/jamainternmed.2020.5921

N/A

0DataRank · unranked

39 citations

Miloš D. Miljković, Vinay Prasad, Patrick DeMartino

Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell Therapy

medRxiv(2024)10.1101/2024.01.03.24300770

N/A

0DataRank · unranked

15 citations

Gregory Sahagian, Marc H. Feinberg, Charles A. Stewart, Christopher M. Jewell, Metin Kurtoğlu +5 more

In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102918

N/A

0DataRank · unranked

0 citations

Susan Manzi, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard

In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.

UNC Libraries(2024)10.17615/4bda-ea57

N/A

0DataRank · unranked

0 citations

Tuan Vu, Miloš D. Miljković, Susan Manzi, Tahseen Mozaffar, James F. Howard

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002193

N/A

0DataRank · unranked

43 citations

Miloš D. Miljković, Thomas A. Fleisher, Stefania Pittaluga, Jennifer Hsu-Albert, Bonita R. Bryant +7 more